Skip to main content

Table 2 Baseline medications

From: Risk stratification and mortality prediction in octo- and nonagenarians with peripheral artery disease: a retrospective analysis

   ≥ 80 years old (n = 123)  < 80 years old (n = 123)  
Antiplatelet therapy 82 (67%) 110 (90%) 0.0001
VKA 15 (12%) 10 (8%) 0.0001
DOACs 28 (23%) 2 (2%) 0.0001
Statin therapy 79 (64%) 95 (77%) 0.035
ACE- inhibitor 57 (46%) 64 (52%) 0.444
AT-II-receptor antagonist 31 (25%) 34 (28%) 0.773
Beta-blockers 73 (60%) 80 (65%) 0.430
Calcium channel blockers 47 (38%) 47 (38%) 1
Aldosterone antagonists 18 (15%) 13 (11%) 0.443
Thiazides 35 (28%) 30 (24%) 0.563
Loop diuretics 55 (45%) 35 (28%) 0.008
  1. VKA, Vitamin K antagonists; DOACs, Directs oral anticoagulants; ACE, angiotensin converting enzyme